Xinyi Wu
Beijing, 100045, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Significant PK variability of plasma-derived FIX concentrates in chinese children with Haemophilia B: A fixed single-dose study of factor IX-CTBB.
Journal: Global medical genetics
Published: January 09, 2025
A comparison of My Precise Dose and WAPPS-Hemo as dosing tools for optimizing prophylaxis in children with hemophilia A treated with BAY 81-8973.
Journal: Thrombosis research
Published: December 25, 2024
Development and internal validation of a clinical prediction model for individualized dosing of BAY 81-8973, A full-length recombinant factor VIII, in pediatric patients with haemophilia A.
Journal: Thrombosis research
Published: July 18, 2023
Exploration of the minimum necessary FVIII level at different physical activity levels in pediatric patients with hemophilia A.
Journal: Frontiers in pediatrics
Published: September 15, 2022
Enhanced pharmacokinetics and reduced bleeds in boys with hemophilia A after switching to Kovaltry from other standard half-life factor VIII concentrates.
Journal: Research and practice in thrombosis and haemostasis
Published: January 23, 2022
Pharmacokinetic-guided prophylaxis improved clinical outcomes in paediatric patients with severe haemophilia A.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: February 11, 2021
Low-dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors.
Journal: Research and practice in thrombosis and haemostasis
Published: February 10, 2021
Pharmacokinetic study of Kovaltry in thirty-five pediatric patients aged <12 years with severe hemophilia A.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: December 16, 2020
A previously treated severe haemophilia A patient developed high-titre inhibitor after vaccinations.
A previously treated severe haemophilia A patient developed high-titre inhibitor after vaccinations.
Journal: International journal of immunopathology and pharmacology
Published: July 07, 2020
Comparative pharmacokinetics of Kogenate FS and Kovaltry in 14 Chinese paediatric patients with haemophilia A: A single-centre study.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: April 19, 2020
Last Updated: 09/26/2026